Novo Nordisk Falls On Lowered Guidance. Pharma Giant Names New CEO.Investors Business Daily • 07/29/25
Maziar Mike Doustdar appointed as president and chief executive officer of Novo NordiskGlobeNewsWire • 07/29/25
Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, OzempicMarket Watch • 07/29/25
Thousands of Americans are being forced to switch from Zepbound to Wegovy as a result of new coverage restrictions by CVS Caremark. ‘I just wish they would trust my doctor.WSJ • 07/27/25
European regulatory authority adopts positive opinion for Novo Nordisk's Alhemo® (concizumab), recommending label expansion to treat haemophilia A and B without inhibitorsGlobeNewsWire • 07/25/25
Novo Nordisk (NVO) is a Top-Ranked Momentum Stock: Should You Buy?Zacks Investment Research • 07/24/25
This Weight-Loss Stock Sank After Earnings. It's Still a Risk for Eli Lilly, Novo Nordisk.Barrons • 07/24/25